IRVINE, Calif., Nov 17 (Bernama-BUSINESS WIRE) — SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it has entered into a Consulting Agreement with BLEZ ASIA Co., Ltd. (Headquarters: Bangkok, Thailand; CEO: Naoki Iida; “BLEZ”), which operates more than 20 pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriates and local patients. The partnership is a key component of SBC’s broader Asia strategy and represents a significant step toward full-scale entry into the rapidly growing Thai aesthetic medicine market. Under the agreement, SBC will provide comprehensive management support to a new clinic focused primarily on dermatological treatments such as pigmentation and spot removal, which BLEZ is preparing to open in Bangkok. SBC will advise on clinical protocol development, aligned with SBC’s quality standards, and assist in selecting medical devices and treatment methods optimized for local skin characteristics and environmental conditions. The clinic is expected to commence operations by year-end in the Asok district of Bangkok.
SBC operates a network of over 250 clinics worldwide, welcoming more than 6 million patient visits annually. By combining SBC’s proven expertise in delivering high-quality and safe aesthetic medical services developed in Japan with BLEZ’s trusted local presence, the two companies aim to establish a solid foothold among Japanese expatriates in Thailand. Following validation of service demand and operational performance, SBC and BLEZ intend to expand patient acquisition to the broader Thai market and pursue incremental growth opportunities across ASEAN.
